Literature DB >> 12213200

Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genes.

Jason A Powell1, Alison E Gardner, Anthony J Bais, Susan J Hinze, Elizabeth Baker, Scott Whitmore, Joanna Crawford, Marina Kochetkova, Hayley E Spendlove, Norman A Doggett, Grant R Sutherland, David F Callen, Gabriel Kremmidiotis.   

Abstract

Loss of heterozygosity (LOH) of chromosome 16q24.3 is a common genetic alteration observed in invasive ductal and lobular breast carcinomas. We constructed a physical map and generated genomic DNA sequence data spanning 2.4 Mb in this region. Detailed in silico and in vitro analyses of the genomic sequence data enabled the identification of 104 genes. It was hypothesized that tumor-suppressor genes would exhibit marked mRNA expression variability in a panel of breast cancer cell lines as a result of downregulation due to mutation or hypermethylation. We examined the mRNA expression profiles of the genes identified at 16q24.3 in normal breast, a normal breast epithelial cell line, and several breast cancer cell lines exhibiting 16q24.3 LOH. Three of the genes, CYBA, Hs.7970, and CBFA2T3, exhibited variability ten times higher than the baseline. The possible role of these genes as tumor suppressors is discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12213200     DOI: 10.1006/geno.2002.6828

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  16 in total

1.  Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.

Authors:  Shravanti Rampalli; L Pavithra; Altaf Bhatt; Tapas K Kundu; Samit Chattopadhyay
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

2.  Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68.

Authors:  Kiran Kumar Nakka; Nidhi Chaudhary; Shruti Joshi; Jyotsna Bhat; Kulwant Singh; Subhrangsu Chatterjee; Renu Malhotra; Abhijit De; Manas Kumar Santra; F Jeffrey Dilworth; Samit Chattopadhyay
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

Review 3.  Cancer and forensic microsatellites.

Authors:  Karen Page; Eleanor A M Graham
Journal:  Forensic Sci Med Pathol       Date:  2008-02-02       Impact factor: 2.007

4.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

5.  Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.

Authors:  George Vasmatzis; Sarah H Johnson; Ryan A Knudson; Rhett P Ketterling; Esteban Braggio; Rafael Fonseca; David S Viswanatha; Mark E Law; N Sertac Kip; Nazan Ozsan; Stefan K Grebe; Lori A Frederick; Bruce W Eckloff; E Aubrey Thompson; Marshall E Kadin; Dragana Milosevic; Julie C Porcher; Yan W Asmann; David I Smith; Irina V Kovtun; Stephen M Ansell; Ahmet Dogan; Andrew L Feldman
Journal:  Blood       Date:  2012-08-01       Impact factor: 22.113

6.  Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.

Authors:  Tom van Wezel; Marcel Lombaerts; Eddy H van Roon; Katja Philippo; Hans J Baelde; Karoly Szuhai; Cees J Cornelisse; Anne-Marie Cleton-Jansen
Journal:  Breast Cancer Res       Date:  2005-10-18       Impact factor: 6.466

7.  Pathway-gene identification for pancreatic cancer survival via doubly regularized Cox regression.

Authors:  Haijun Gong; Tong Tong Wu; Edmund M Clarke
Journal:  BMC Syst Biol       Date:  2014-01-24

8.  MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer.

Authors:  Dayue Liu; Haoming Xia; Fang Wang; Cui Chen; Jianting Long
Journal:  Onco Targets Ther       Date:  2016-08-23       Impact factor: 4.147

9.  Clinical significance of Ankyrin repeat domain 12 expression in colorectal cancer.

Authors:  Rui Bai; Dan Li; Zhong Shi; Xuefeng Fang; Weiting Ge; Shu Zheng
Journal:  J Exp Clin Cancer Res       Date:  2013-05-29

10.  Aberrant CBFA2T3B gene promoter methylation in breast tumors.

Authors:  Anthony J Bais; Alison E Gardner; Olivia L D McKenzie; David F Callen; Grant R Sutherland; Gabriel Kremmidiotis
Journal:  Mol Cancer       Date:  2004-08-10       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.